• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PI(4,5)P2 5-磷酸酶 A 调节 PI3K/Akt 信号通路,在人类黑色素瘤中发挥肿瘤抑制作用。

PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma.

机构信息

School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales 2308, Australia.

出版信息

Nat Commun. 2013;4:1508. doi: 10.1038/ncomms2489.

DOI:10.1038/ncomms2489
PMID:23443536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3586716/
Abstract

Inositol polyphosphate 5-phosphatases can terminate downstream signalling of phosphatidylinositol-3 kinase; however, their biological role in the pathogenesis of cancer is controversial. Here we report that the inositol polyphosphate 5-phosphatase, phosphatidylinositol 4,5-bisphosphate 5-phosphatase, has a tumour suppressive role in melanoma. Although it is commonly downregulated in melanoma, overexpression of phosphatidylinositol 4,5-bisphosphate 5-phosphatase blocks Akt activation, inhibits proliferation and undermines survival of melanoma cells in vitro, and retards melanoma growth in a xenograft model. In contrast, knockdown of phosphatidylinositol 4,5-bisphosphate 5-phosphatase results in increased proliferation and anchorage-independent growth of melanocytes. Although DNA copy number loss is responsible for downregulation of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in a proportion of melanomas, histone hypoacetylation mediated by histone deacetylases HDAC2 and HDAC3 through binding to the transcription factor Sp1 at the PIB5PA gene promoter appears to be another commonly involved mechanism. Collectively, these results establish the tumour suppressive role of phosphatidylinositol 4,5-bisphosphate 5-phosphatase and reveal mechanisms involved in its downregulation in melanoma.

摘要

肌醇多磷酸 5-磷酸酶可以终止磷脂酰肌醇-3-激酶的下游信号转导;然而,它们在癌症发病机制中的生物学作用存在争议。在这里,我们报告说,肌醇多磷酸 5-磷酸酶,即磷脂酰肌醇 4,5-二磷酸 5-磷酸酶,在黑色素瘤中具有肿瘤抑制作用。尽管它在黑色素瘤中通常下调,但过表达磷脂酰肌醇 4,5-二磷酸 5-磷酸酶会阻断 Akt 激活,抑制黑色素瘤细胞的增殖并破坏其体外存活能力,并在异种移植模型中延缓黑色素瘤的生长。相比之下,敲低磷脂酰肌醇 4,5-二磷酸 5-磷酸酶会导致黑素细胞增殖和非依赖性生长增加。虽然在一部分黑色素瘤中,DNA 拷贝数的丢失导致磷脂酰肌醇 4,5-二磷酸 5-磷酸酶的下调,但通过与转录因子 Sp1 结合,组蛋白去乙酰化酶 HDAC2 和 HDAC3 介导的组蛋白乙酰化似乎是另一种常见的涉及机制。总之,这些结果确立了磷脂酰肌醇 4,5-二磷酸 5-磷酸酶的肿瘤抑制作用,并揭示了其在黑色素瘤中下调的相关机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/c6b95cdd7612/ncomms2489-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/7ee186bba200/ncomms2489-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/2c7503036d5b/ncomms2489-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/cecfd893b612/ncomms2489-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/93a75d56272c/ncomms2489-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/04d54b496554/ncomms2489-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/8d83e4bfe0e9/ncomms2489-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/aeb4d8348de9/ncomms2489-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/c6b95cdd7612/ncomms2489-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/7ee186bba200/ncomms2489-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/2c7503036d5b/ncomms2489-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/cecfd893b612/ncomms2489-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/93a75d56272c/ncomms2489-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/04d54b496554/ncomms2489-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/8d83e4bfe0e9/ncomms2489-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/aeb4d8348de9/ncomms2489-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2186/3586716/c6b95cdd7612/ncomms2489-f8.jpg

相似文献

1
PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma.PI(4,5)P2 5-磷酸酶 A 调节 PI3K/Akt 信号通路,在人类黑色素瘤中发挥肿瘤抑制作用。
Nat Commun. 2013;4:1508. doi: 10.1038/ncomms2489.
2
The INPP4B paradox: Like PTEN, but different.肌醇多磷酸-4-磷酸酶β(INPP4B)的矛盾之处:与第10号染色体缺失的磷酸酶及张力蛋白同源物(PTEN)相似,但又有所不同。
Adv Biol Regul. 2021 Dec;82:100817. doi: 10.1016/j.jbior.2021.100817. Epub 2021 Jun 16.
3
INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.在一部分黑色素瘤中,INPP4B通过SGK3上调并作为致癌驱动因子发挥作用。
Oncotarget. 2015 Nov 24;6(37):39891-907. doi: 10.18632/oncotarget.5359.
4
Oncogenic suppression of PHLPP1 in human melanoma.人黑色素瘤中PHLPP1的致癌抑制作用。
Oncogene. 2014 Sep 25;33(39):4756-66. doi: 10.1038/onc.2013.420. Epub 2013 Oct 14.
5
INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.INPP4B和PTEN缺失导致三阴性乳腺癌中PI-3,4-P2积累及PI3K抑制。
Mol Cancer Res. 2017 Jun;15(6):765-775. doi: 10.1158/1541-7786.MCR-16-0183. Epub 2017 Feb 14.
6
Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.磷酸肌醇磷酸酶对癌症中PI3K效应信号的调控
Biosci Rep. 2017 Feb 10;37(1). doi: 10.1042/BSR20160432. Print 2017 Feb 28.
7
Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.血清撤除诱导分化中的3T3-L6成肌细胞中磷酸肌醇3激酶脂质蓄积:Ship2和PTEN的不同作用
Mol Cell Biol. 2007 Dec;27(23):8098-112. doi: 10.1128/MCB.00756-07. Epub 2007 Sep 24.
8
A tumor suppressor function for the lipid phosphatase INPP4B in melanocytic neoplasms.抑癌基因 INPP4B 在黑素细胞肿瘤中的脂质磷酸酶功能。
J Invest Dermatol. 2014 May;134(5):1359-1368. doi: 10.1038/jid.2013.511. Epub 2013 Nov 28.
9
Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers.肌醇多聚磷酸 4-磷酸酶 II 调节 PI3K/Akt 信号通路,并且在人基底样乳腺癌中缺失。
Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22231-6. doi: 10.1073/pnas.1015245107. Epub 2010 Dec 2.
10
Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines.PTEN和SHIP2对人前列腺来源细胞系中蛋白激酶B活性的调节作用
Cell Signal. 2007 Jan;19(1):129-38. doi: 10.1016/j.cellsig.2006.05.029. Epub 2006 Jun 7.

引用本文的文献

1
Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanoma.用于增强免疫检查点抑制剂治疗黑色素瘤疗效的表观遗传修饰剂。
Transl Oncol. 2025 Jun 23;59:102452. doi: 10.1016/j.tranon.2025.102452.
2
Epigenetics and ultraviolet radiation: Implications for skin ageing and carcinogenesis.表观遗传学与紫外线辐射:对皮肤衰老和致癌作用的影响。
Skin Health Dis. 2024 Jul 5;4(6):e410. doi: 10.1002/ski2.410. eCollection 2024 Dec.
3
Inhibition of α4β1 Integrin Activity by Small Tellurium Compounds Regulates PD-L1 Expression and Enhances Antitumor Effects.

本文引用的文献

1
Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL.肌醇 5-磷酸酶:Lowe 综合征蛋白 OCRL 的研究进展。
Trends Biochem Sci. 2012 Apr;37(4):134-43. doi: 10.1016/j.tibs.2012.01.002. Epub 2012 Feb 28.
2
In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma.在致癌性 BRAF 诱导的黑色素瘤小鼠模型中体内鉴定肿瘤抑制性 PTEN ceRNAs。
Cell. 2011 Oct 14;147(2):382-95. doi: 10.1016/j.cell.2011.09.032.
3
MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma.
小分子碲化物通过抑制 α4β1 整合素活性调节 PD-L1 表达并增强抗肿瘤作用。
Int J Biol Sci. 2024 Aug 12;20(11):4407-4423. doi: 10.7150/ijbs.95350. eCollection 2024.
4
PRL1 and PRL3 promote macropinocytosis via its lipid phosphatase activity.PRL1 和 PRL3 通过其脂质磷酸酶活性促进巨胞饮作用。
Theranostics. 2024 May 27;14(9):3423-3438. doi: 10.7150/thno.93127. eCollection 2024.
5
KMT2A and chronic inflammation as potential drivers of sporadic parathyroid adenoma.KMT2A 和慢性炎症作为散发甲状旁腺腺瘤的潜在驱动因素。
Clin Transl Med. 2024 Jun;14(6):e1734. doi: 10.1002/ctm2.1734.
6
CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance.CD133 依赖性激活磷酸肌醇 3-激酶/AKT/雷帕霉素靶蛋白信号通路在黑色素瘤进展和耐药中的作用。
Cells. 2024 Jan 26;13(3):240. doi: 10.3390/cells13030240.
7
CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation.CKB 通过隔离和抑制 AKT 激活来抑制上皮-间质转化和前列腺癌进展。
Neoplasia. 2021 Nov;23(11):1147-1165. doi: 10.1016/j.neo.2021.09.005. Epub 2021 Oct 24.
8
KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer.KDM1A 抑制增强了雷帕霉素治疗子宫内膜癌的疗效。
Cancer Lett. 2022 Jan 1;524:219-231. doi: 10.1016/j.canlet.2021.10.019. Epub 2021 Oct 18.
9
Epigenetic Regulation in Melanoma: Facts and Hopes.黑色素瘤中的表观遗传调控:事实与展望。
Cells. 2021 Aug 11;10(8):2048. doi: 10.3390/cells10082048.
10
Targeting SHIP1 and SHIP2 in Cancer.癌症中SHIP1和SHIP2的靶向治疗
Cancers (Basel). 2021 Feb 20;13(4):890. doi: 10.3390/cancers13040890.
miR-149*,一种 p53 反应性 microRNA,作为致癌调节因子在人类黑色素瘤中发挥作用。
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15840-5. doi: 10.1073/pnas.1019312108. Epub 2011 Sep 6.
4
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.BRAF V600E 突变型黑色素瘤患者采用威罗菲尼治疗后生存改善。
N Engl J Med. 2011 Jun 30;364(26):2507-16. doi: 10.1056/NEJMoa1103782. Epub 2011 Jun 5.
5
BRAF targeted therapy changes the treatment paradigm in melanoma.BRAF 靶向治疗改变了黑色素瘤的治疗模式。
Nat Rev Clin Oncol. 2011 May 24;8(7):426-33. doi: 10.1038/nrclinonc.2011.69.
6
SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.SHIP2 具有多种功能:既能作为 PtdIns(3,4,5)P₃ 水平的负调控因子,又能作为 PtdIns(3,4)P₂ 产生的正调控因子,还具有内在的对接特性。
J Cell Biochem. 2011 Sep;112(9):2203-9. doi: 10.1002/jcb.23146.
7
Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress.内质网应激时 Ets-1 介导 XBP-1 下游的 Mcl-1 在人黑色素瘤细胞中的上调。
Oncogene. 2011 Aug 25;30(34):3716-26. doi: 10.1038/onc.2011.87. Epub 2011 Mar 21.
8
PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression.PTEN 缺失通过抑制 BIM 表达赋予黑色素瘤细胞对 BRAF 抑制剂的耐药性。
Cancer Res. 2011 Apr 1;71(7):2750-60. doi: 10.1158/0008-5472.CAN-10-2954. Epub 2011 Feb 11.
9
PTEN level in tumor suppression: how much is too little?抑癌基因 PTEN 的失活:过少会带来何种影响?
Cancer Res. 2011 Feb 1;71(3):629-33. doi: 10.1158/0008-5472.CAN-10-2488. Epub 2011 Jan 25.
10
Mutant BRAF melanomas--dependence and resistance.突变型 BRAF 黑色素瘤——依赖性和耐药性。
Cancer Cell. 2011 Jan 18;19(1):11-5. doi: 10.1016/j.ccr.2011.01.008.